This National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) award of $275,000 to Envision Health Technologies Inc. aims to develop a novel adaptive perimetry software tool for the early detection and monitoring of vision loss due to glaucoma. The project will use advanced adaptive testing algorithms, eye-tracking, and retinal pathophysiology modeling to improve the sensitivity and specificity of functional visual field defect detection compared to the current standard of care. This SBIR Phase I project seeks to address the significant public health challenge posed by the increasing prevalence of glaucoma, a leading cause of preventable blindness that often goes undetected in its early stages. Successful completion of this effort could facilitate earlier clinical intervention and reduce the burden of irreversible vision loss from this disease.
Generated 1/28/25, 9:36 AM